Unlock Premium for Just $9.99/Month – Special Launch Offer, Limited Time Only
Get Premium
BTMD biote Corp
- Stocks
- Healthcare
- NASDAQ: BTMD
Price (delayed)
$3.74
Market cap
$204.62M
P/E Ratio
41.56
Dividend/share
N/A
EPS
$0.09
Enterprise value
$276.14M
Highlights
The equity has grown by 19% from the previous quarter
BTMD's debt is down by 9% since the previous quarter and by 3.5% year-on-year
biote's quick ratio has plunged by 79% YoY and by 9% from the previous quarter
The EPS has plunged by 78% from the previous quarter and by 31% YoY
Key stats
What are the main financial stats of BTMD
Market
Valuations
Earnings
Shares outstanding
54.71M
Market cap
$204.62M
Enterprise value
$276.14M
Price to earnings (P/E)
41.56
Price to book (P/B)
N/A
Price to sales (P/S)
0.65
EV/EBIT
18.25
EV/EBITDA
14.15
EV/Sales
1.4
Revenue
$197.19M
Gross profit
$139.06M
Operating income
$31.61M
Net income
$3.16M
EBIT
$15.13M
EBITDA
$19.52M
Free cash flow
$38.29M
Per share
Balance sheet
Liquidity
EPS
$0.09
EPS diluted
$0.09
Free cash flow per share
$1.12
Book value per share
-$1.95
Revenue per share
$5.75
TBVPS
$3.13
Total assets
$122.37M
Total liabilities
$224.57M
Debt
$110.86M
Equity
-$105.93M
Working capital
$16.61M
Debt to equity
-1.05
Current ratio
1.32
Quick ratio
0.91
Net debt/EBITDA
3.66
Margins
Efficiency
Dividend
EBITDA margin
9.9%
Gross margin
70.5%
Net margin
1.6%
Operating margin
16%
Return on assets
2.6%
Return on equity
N/A
Return on invested capital
11.4%
Return on capital employed
21.4%
Return on sales
7.7%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
BTMD stock price
How has the biote stock price performed over time
Intraday
11.98%
1 week
14.37%
1 month
15.08%
1 year
-38.39%
YTD
-39.48%
QTD
12.31%
Financial performance
How have biote's revenue and profit performed over time
Revenue
$197.19M
Gross profit
$139.06M
Operating income
$31.61M
Net income
$3.16M
Gross margin
70.5%
Net margin
1.6%
BTMD's net margin has dropped by 69% since the previous quarter and by 11% year-on-year
BTMD's net income has plunged by 69% from the previous quarter and by 4.8% YoY
BTMD's operating income is up by 10% year-on-year but it is down by 8% since the previous quarter
The company's operating margin fell by 10% QoQ but it rose by 3.2% YoY
Price vs fundamentals
How does BTMD's price correlate with its fundamentals
Growth
What is biote's growth rate over time
Valuation
What is biote stock price valuation
P/E
41.56
P/B
N/A
P/S
0.65
EV/EBIT
18.25
EV/EBITDA
14.15
EV/Sales
1.4
The EPS has plunged by 78% from the previous quarter and by 31% YoY
The P/E is 30% more than the last 4 quarters average of 32.0
The equity has grown by 19% from the previous quarter
The stock's price to sales (P/S) is 41% less than its last 4 quarters average of 1.1
BTMD's revenue is up by 6% year-on-year and by 2.1% since the previous quarter
Efficiency
How efficient is biote business performance
The return on assets has dropped by 67% since the previous quarter but it has grown by 8% year-on-year
BTMD's ROIC is up by 41% year-on-year but it is down by 29% since the previous quarter
The ROS has contracted by 34% from the previous quarter but it has grown by 15% YoY
Dividends
What is BTMD's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for BTMD.
Financial health
How did biote financials performed over time
biote's total assets is 46% lower than its total liabilities
biote's quick ratio has plunged by 79% YoY and by 9% from the previous quarter
The current ratio has shrunk by 76% YoY and by 12% QoQ
BTMD's debt to equity has surged by 73% year-on-year but it is down by 12% since the previous quarter
The equity has grown by 19% from the previous quarter
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.